According to the American Psychiatric Association, “Gender dysphoria involves a conflict between a person’s physical or assigned gender and the gender with which he/she/they identify. Such people with gender dysphoria often experience significant distress and/or problems functioning associated with this conflict between the way they feel and think of themselves (referred to as experienced or expressed gender) and their physical or assigned gender.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/gender-dysphoria-market
The Gender Dysphoria Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Gender Dysphoria market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Gender Dysphoria treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Gender Dysphoria Market Key Facts
-
According to the National Health Services (NHS), in 2018/19 around 8,000 people were referred to adult gender dysphoria services in England.
-
According to a recent national survey, 1.4 million individuals (0.6%) in the United States identify as transgender.
-
According to an analysis of national probability samples in 2016, there were 390 per 100,000 adults who were transgender. However, it also suggested that future surveys will probably observe a higher prevalence.
-
According to the Blacks Medical Dictionary, gender identity disorder occurs in one in 30,000 male births and one in 100,000 female births.
Key Benefits of Gender Dysphoria Market Report
-
Gender Dysphoria market report provides an in-depth analysis of Gender Dysphoria Market Size, Share, Trend, and Epidemiology Forecast till 2030 in the seven major markets (i.e. the United States, EU5 (Germany, Italy, Spain, France, and the UK) and Japan.
-
The report will help in developing business strategies by understanding the Gender Dysphoria Market Trends, recent developments, key players, and future market competition that will shape and drive the market growth in the upcoming years.
-
The market report covers the Gender Dysphoria current treatment practices, emerging drugs, market share of the individual therapies in the seven major markets.
-
The report provides a detailed assessment of the Gender Dysphoria market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors.
The market size of Gender Dysphoria is anticipated to increase during the study period owing to the increasing prevalent population of Gender Dysphoria patients in the 7MM, along with the expected entry of the emerging therapy.
It is observed that people with gender dysphoria have higher rates of mental health conditions. Diagnosis and treatment play a key role in the management of gender dysphoria. Some estimates say that people with gender dysphoria will have some other mental health diagnosis in their lifetime. In order to provide health outcomes, the Gender Dysphoria therapeutic market needs technological advancements and improved understanding in order to accurately diagnose and treat the patients. The market size of gender dysphoria is currently governed by existing therapies which is expected to grow during the forecast period owing to the rise in the number of cases and awareness.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Gender Dysphoria market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Gender Dysphoria market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Gender Dysphoria Epidemiology
The epidemiology section covers insights about the historical and current Gender Dysphoria patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Gender Dysphoria Epidemiology Segmentation
-
Total Prevalent Cases of Gender Dysphoria
-
Age-specific Cases of Gender Dysphoria
-
Diagnosed Cases of Gender Dysphoria
-
Gender-specific Cases of Gender Dysphoria
-
Comorbidities associated with Gender Dysphoria
Gender Dysphoria Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gender Dysphoria market or expected to get launched in the market during the study period. The analysis covers Gender Dysphoria market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Gender Dysphoria Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the Gender Dysphoria market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisition, and merger, licensing, patent details, and other information for Gender Dysphoria emerging therapies.
The mainstay treatment option in the Gender Dysphoria Landscape is Hormonal Therapy. Research is underway to innovate technological advancements and improve healthcare policies to uplift the lives of individuals with gender dysphoria. Although, no pharmaceutical company is currently involved in developing an improvement over existing treatment therapies yet some trials are underway sponsored by other universities and organizations.
Table of Content
1. Key Insights
2. Executive Summary
3. Gender Dysphoria Competitive Intelligence Analysis
4. Gender Dysphoria Market Overview at a Glance
5. Gender Dysphoria Disease Background and Overview
6. Gender Dysphoria Patient Journey
7. Gender Dysphoria Epidemiology and Patient Population
8. Gender Dysphoria Treatment Algorithm, Current Treatment, and Medical Practices
9. Gender Dysphoria Unmet Needs
10. Key Endpoints of Gender Dysphoria Treatment
11. Gender Dysphoria Marketed Products
12. Gender Dysphoria Emerging Therapies
13. Gender Dysphoria Seven Major Market Analysis
14. Attribute Analysis
15. Gender Dysphoria Market Outlook (7 major markets)
16. Gender Dysphoria Access and Reimbursement Overview
17. KOL Views on the Gender Dysphoria Market.
18. Gender Dysphoria Market Drivers
19. Gender Dysphoria Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/gender-dysphoria-market
Latest Reports By DelveInsight
Gender Dysphoria Pipeline Insight
“Gender Dysphoria Pipeline Insights, 2021” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Gender Dysphoria market.
Healthcare Blogs –
Elastomeric Pump Market
As per DelveInsight, the market for Elastomeric Pumps consists of many leading companies including many local players, especially in Europe. The key companies operating in the ElastomericPump market include B. Braun Medical, Baxter International, Daiken Medical, Nipro Corporation, Halyard Health, Heka Medical, Leventon, Avanos Medical, Smiths Medical, and others. Apart from being cost-effective, some other factors such as versatile usage, and favorable reimbursement policies are expected to drive the Elastomeric Pumps market growth in the coming. For more details, visit: Key Companies in the Elastomeric Pump Market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/